Abraham Olufunmilola, Buechel Megan, Gay Sommer, Szela Lisa, Decker Catherine A, Braun Andrew T
University of Wisconsin-Madison School of Pharmacy, Social and Administrative Sciences Division (OA, MB, SG, LS), Madison, WI.
School of Medicine and Public Health, University of Wisconsin-Madison (ATB, CAD), Madison, WI.
J Pediatr Pharmacol Ther. 2022;27(3):270-276. doi: 10.5863/1551-6776-27.3.270. Epub 2022 Mar 21.
Cystic fibrosis (CF) is a genetic disease that requires complex, lifelong treatment regimens to maintain health and reduce disease progression. The aims of this study were 1) to gain the perspectives of multiple health professions to understand medication and well-being challenges of people living with CF; and 2) to apply the Systems Engineering Initiative for Patient Safety (SEIPS) model to further identify opportunities for pharmacists to support people with CF.
Health care professionals were recruited from a Cystic Fibrosis Center in the Midwest, to participate in audio-recorded semistructured interviews. Topics examined during the interviews included medication education for patients as well as experiences with outpatient, specialty, and community pharmacists. The themes assessed during the pharmacist interviews included support for people living with CF, preferences in conducting medication education, and pharmacist-specific counseling. Interview transcripts were thematically analyzed into categories to determine major themes. Prevalent codes were categorized into 5 major themes guided by the SEIPS model. Interrater reliability was strong (kappa = 0.94).
Five major themes were identified: 1) patient tasks; 2) external environment; 3) organizational conditions; 4) patient medication education; and 5) pharmacists' roles and tasks. Professionals identified the importance of the pharmacist on the multidisciplinary CF care team to enhance patient-centered care for people living with CF.
This study highlights health care professionals' views on the unique skillset that pharmacists add to the care team, including a reduction in medication errors, improved adherence, and overall enhanced patient care.
囊性纤维化(CF)是一种遗传性疾病,需要复杂的终身治疗方案来维持健康并减缓疾病进展。本研究的目的是:1)获取多个医疗专业人员的观点,以了解CF患者的用药和健康挑战;2)应用患者安全系统工程倡议(SEIPS)模型,进一步确定药剂师支持CF患者的机会。
从中西部的一个囊性纤维化中心招募医疗保健专业人员,参与录音的半结构化访谈。访谈中探讨的主题包括患者的用药教育以及与门诊、专科和社区药剂师的经历。药剂师访谈中评估的主题包括对CF患者的支持、开展用药教育的偏好以及药剂师特定的咨询。访谈记录经主题分析归类,以确定主要主题。根据SEIPS模型,将普遍出现的编码分为5个主要主题。评分者间信度很强(kappa = 0.94)。
确定了5个主要主题:1)患者任务;2)外部环境;3)组织条件;4)患者用药教育;5)药剂师的角色和任务。专业人员认识到药剂师在多学科CF护理团队中的重要性,以加强以患者为中心的CF患者护理。
本研究突出了医疗保健专业人员对药剂师为护理团队所带来的独特技能的看法,包括减少用药错误、提高依从性以及全面加强患者护理。